Julphar Diabetes facility launched in RAK
- United Arab Emirates: Monday, September 10 - 2012 at 12:21
Ras Al Khaimah-based Gulf Pharmaceutical Industries (Julphar) has launched Julphar Diabetes for manufacturing and commercialising diabetes products, Gulf Today has reported. The new Dhs500m plant has a total capacity of 1.5 tonnes of insulin, or roughly 45 million vials per year. Capacity will be scaled up based on demand for both crystals, Julphar said.
- Arabtec workers stage strike in Abu Dhabi, Dubai
- Emirates says A380 wing repair is behind schedule
- Dell to start shipping Ophelia thumb PC next July
- SKAI Holdings announces $1bn hotel project on...
- Etihad Airways boosts services and operations...
- Noor Islamic Bank reports net profits of Dhs75....
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / 4C and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / 4C can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / 4C.
In no event shall AME Info FZ LLC / 4C be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.